Lisata Therapeutics (LSTA) Institutional Ownership $2.64 -0.09 (-3.30%) As of 02:11 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Lisata Therapeutics (NASDAQ:LSTA)CurrentInstitutional OwnershipPercentage8.94%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$112.42KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$159.37K Get LSTA Insider Trade Alerts Want to know when executives and insiders are buying or selling Lisata Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LSTA Institutional Buying and Selling by Quarter Lisata Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/7/2025BML Capital Management LLC216,853$510K0.4%-23.8%2.517% 2/17/2025Citadel Advisors LLC23,273$69K0.0%N/A0.277% 2/14/2025Dimensional Fund Advisors LP25,226$75K0.0%+45.5%0.301% 8/9/2024Dimensional Fund Advisors LP17,336$60K0.0%+48.2%0.209% 4/23/2024BML Capital Management LLC284,669$888K0.6%+5.5%3.426% 1/30/2024BML Capital Management LLC269,839$737K0.6%+10.7%3.315% 2/13/2023BML Capital Management LLC243,839$617K0.6%N/A3.102% (Data available from 1/1/2016 forward) LSTA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LSTA shares? During the previous two years, the following institutional investors and hedge funds held shares of Lisata Therapeutics shares: BML Capital Management LLC ($510K), and Dimensional Fund Advisors LP ($75K), Citadel Advisors LLC ($69K).Learn more on Lisata Therapeutics' institutional investors. What percentage of Lisata Therapeutics' stock is owned by institutional investors? 8.94% of Lisata Therapeutics' stock is owned by institutional investors. Learn more on LSTA's institutional investor holdings. Which institutional investors have been buying Lisata Therapeutics' stock? The following institutional investors have purchased Lisata Therapeutics' stock in the last 24 months: BML Capital Management LLC ($40.83K), Citadel Advisors LLC ($23.27K), and Dimensional Fund Advisors LP ($13.53K). How much institutional buying is happening at Lisata Therapeutics? Institutional investors have bought a total of 36,798 shares in the last 24 months. This purchase volume represents approximately $112.42K in transactions. Which of Lisata Therapeutics' major shareholders have been selling company stock? The following institutional investors have sold Lisata Therapeutics stock in the last 24 months: BML Capital Management LLC ($67.82K). How much institutional selling is happening at Lisata Therapeutics? Institutional investors have sold a total of 67,816 shares in the last 24 months. This volume of shares sold represents approximately $159.37K in transactions. Related Companies Cabaletta Bio Institutional Ownership IO Biotech Institutional Ownership Invivyd Institutional Ownership VolitionRx Institutional Ownership Coherus Oncology Institutional Ownership TScan Therapeutics Institutional Ownership Forte Biosciences Institutional Ownership MacroGenics Institutional Ownership Climb Bio Institutional Ownership Surrozen Institutional Ownership This page (NASDAQ:LSTA) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe $100 Trillion AI Story No One Is Telling YouJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lisata Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lisata Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LSTA Stock Alerts